R. Wayne Davies

CEO
parkure
Malta

Business Expert Microbiology
Biography

Wayne combines international level scientific achievement with extensive business experience. He was Vice-President   for Science of Allelix Biopharmaceuticals in Canada, and CEO of Neuropa Ltd. and UmanGenomics AB. He is currently CEO of Brainwave-Discovery Ltd. and Scientific Director of Pathfinder Cell Therapy Inc. Wayne was also Professor of Biotechnology at the University of Glasgow, and is now an Honorary Professor of the University of Edinburgh. He is an expert in genetics, molecular biology and neuroscience, with many publications in major scientific journals. He was elected as a member of the prestigious European Molecular Biology Organisation for his pioneering work on RNA catalysis. Among other achievements, he was instrumental in developing a rat Parkinson’s disease model and showed that loss of PKCg function caused parkinsonism. Wayne brings directly relevant scientific and biotechnology business experience to Parkure. Wayne combines international level scientific achievement with extensive business experience. He was Vice-President   for Science of Allelix Biopharmaceuticals in Canada, and CEO of Neuropa Ltd. and UmanGenomics AB. He is currently CEO of Brainwave-Discovery Ltd. and Scientific Director of Pathfinder Cell Therapy Inc. Wayne was also Professor of Biotechnology at the University of Glasgow, and is now an Honorary Professor of the University of Edinburgh. He is an expert in genetics, molecular biology and neuroscience, with many publications in major scientific journals. He was elected as a member of the prestigious European Molecular Biology Organisation for his pioneering work on RNA catalysis. Among other achievements, he was instrumental in developing a rat Parkinson’s disease model and showed that loss of PKCg function caused parkinsonism. Wayne brings directly relevant scientific and biotechnology business experience to Parkure.

Research Intrest

fermentation